{"name":"Kineta Inc.","slug":"kineta-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"KVA12123 - Dose Expansion","genericName":"KVA12123 - Dose Expansion","slug":"kva12123-dose-expansion","indication":"Other","status":"phase_1"},{"name":"KVA12123 Plus Pembrolizumab - Dose Expansion","genericName":"KVA12123 Plus Pembrolizumab - Dose Expansion","slug":"kva12123-plus-pembrolizumab-dose-expansion","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"KVA12123 - Dose Expansion","genericName":"KVA12123 - Dose Expansion","slug":"kva12123-dose-expansion","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"KVA12123 Plus Pembrolizumab - Dose Expansion","genericName":"KVA12123 Plus Pembrolizumab - Dose Expansion","slug":"kva12123-plus-pembrolizumab-dose-expansion","phase":"phase_1","mechanism":"Combination therapy pairing KVA12123 with pembrolizumab, a PD-1 checkpoint inhibitor that enhances T-cell mediated anti-tumor immunity.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOVkJOUFdXdVk0dDJaaW9QN0NITG13cDROTDBxUS1Bb2NHVEVWY2Z6QmY3U19vNzlsTmhTNUgzMHpITmFKV2JlVVJ3RUhxMUk5cnNyZlFqM0tFc0VNR0FoelNTQjdsMk1SMFZDVFhmMm5pUjlaTC1tVlg0bjk2YzlGRU5SajIzVDZjd0lFNjNSYUJTOWZkeWM5NUlvSml3Um04LW5fMVV6Tm0wdw?oc=5","date":"2025-06-30","type":"pipeline","source":"PR Newswire","summary":"TuHURA Biosciences Completes Acquisition of Kineta - PR Newswire","headline":"TuHURA Biosciences Completes Acquisition of Kineta","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOdXNQcl9Pa2JCZEFxOFlOcXNaZ2Rjek5NdWYtVHBPS0JHQkRVZmJYc0JKdWJaMTlpTEtDRHp3clY1cFF6bDZMOG5xQ25YTDRKYmRGZFc4aG5rRDA4dWtuN0JJTEdNUUNraUl4aDBrVThKczZkNUtLdU5KX0NRM3E0YnlfNXMxQUpmZi16RXY1N01XcEhOaThJaWVRa1FhZWluSVREcGx2dGFLcHZ3dkMyQTZ5WWdYLUFWTWdzZFV0SG9Ca1BhZ2wta0lRYi1IUnQ1X0ZyME15dmpjWHNyZ3RyX2hhZy1QdEVFazF1ag?oc=5","date":"2025-06-24","type":"deal","source":"Stocktwits","summary":"Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline - Stocktwits","headline":"Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPOEN4cG9fRjVoZHRMZlhZZnc0Z29HZGM1TVo2Ni1VWTVibzJOaEpKTUpnREthOXQ3VXhBMWlXSHc2SGhQVWIyYTZKdDZ6WEI2ZVBmd1dkTWFvbDBfeWFEcHE0MVppT2VkSFduYm1mS1hjQk5mNGxsQUswc1UweDl1bF8zU2ZOd1lFUHdtMTB3UWVMY3UzU2tRNlNKWVgtZjFaVzhCMU1yVUoyMWw1QWVpZEwybDVrb010NnFiOXJYbTBLNTZoalZxa0R6MlFFZEoxN21uUlpXYXBjSUE3OXZBSDlKMk1FS2ZUeHRUVw?oc=5","date":"2025-06-23","type":"regulatory","source":"PR Newswire","summary":"TuHURA Biosciences, Inc. and Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals - PR Newswire","headline":"TuHURA Biosciences, Inc. and Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE4wWG1paGo4b29sZDNDQ2ZkS2tQV2hKcWg4bkMtcXFwRnFhRkZTdmo0TktPUlltbVRwVWdISkVMYm0wYlNFcS1mRXk1VXN3SEsy?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"KA Stock Price, News & Analysis - Stock Titan","headline":"KA Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBySF9VQ1phVnMwY0w3eS1kSmJsSlpwRXh0SGw1UE1mS1VKX215NGFIZVlsaWtkM3lRcWdENTV3VjJCTXRGMEw2WTZ2cXhqNGFXMW5CLU02RmpUbUpqaEdyYndMM19LUlB2b1E?oc=5","date":"2025-03-06","type":"earnings","source":"qz.com","summary":"Kineta Inc. (KANT) reports earnings - qz.com","headline":"Kineta Inc. (KANT) reports earnings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOR3ZCVnMwV0FnZXIyVC1TbXBEQXRJeVdGakhWYXJ4N0NPTk42cGJHSEhYRkZCNzVGV2ZvRGJsMEx6b3QyOGVIR2JrSDJ2NWJDVHBNenFfUEVROXh4dkFGYko4d2VVcjQydzNVZXdsa2tyaEh4TGMycy1aZGFwOThNS0tHZ2RfVEtrRndINFNaQlctdWx2c0NzbTVUdUhMVkFBclJuY1N6eEw?oc=5","date":"2025-02-10","type":"deal","source":"Fierce Biotech","summary":"Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger - Fierce Biotech","headline":"Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9FeW4tbkQ5U0Q2RnJhRGRkM1ZEZUVHUERiNG1nNVVLVl9HX2wyRjRHZ1E2a043MVdNOG84cjNFMFlmVXBoNVhhNk9ndzRseUw0dzJEWTRPN1dJRS1I?oc=5","date":"2024-09-18","type":"pipeline","source":"ChartMill","summary":"KA Stock Price, Quote & Chart | KINETA INC (NASDAQ:KA) - ChartMill","headline":"KA Stock Price, Quote & Chart | KINETA INC (NASDAQ:KA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOWWpYbFhYSE1DT0xobFQ2cGlPd3pmTkVkSUJhaFdXZ0l2VUJlSnBDT0tiN01aTHlDUzR0S2dMMUlZelQwaktudTY5ZkdwU2lJWWNQclJ1bU85XzdhNEV6RjZrVzU5bm0xdW9EakFzeU9rWkhKOExHVkJhWXpqT01BYWhWLU4yeUZJXzI5dWdnbWtHX2dKYmJz?oc=5","date":"2022-06-06","type":"pipeline","source":"BioPharma Dive","summary":"Yumanity’s days as an independent biotech come to a close - BioPharma Dive","headline":"Yumanity’s days as an independent biotech come to a close","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNSEZuUFc4RzhaYldBUGUtNWQ0SXdTcm9MU0xJQVZCUWVydGhfTnhna3RENFJ0UTFuTnpjZkRwVmtiVXYzTmFzVjVBRVJ6N1Q4cjBlVEw4SFVRbFI2UEhGb0Y1Mm1BeTlaWWh3MGV6MVhJMzRLdjdLQkxSd1FlTFptbm5Idm1DbGhmcGdOTTZqZlZPR0l4TnQ0Z0dfQjRjb09udl8xR2ZFVFBMVnBBZFp4RC0zNE5VcTBvOEpSaGlwZUlsWlhMNU5SOXZWd1VTWnB4RXAtS3dVVjFvc2NhMDdzcTdVZTBwWFVrQTdDbQ?oc=5","date":"2022-06-06","type":"pipeline","source":"GlobeNewswire","summary":"Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions - GlobeNewswire","headline":"Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOQnBDQk9RbDRQaVJPcFJTOG83ZGxMREZtbWdWNFVYVWlqa09RUG1peHAxSDhXRUYyVkN5ekg3MFRMMkVFdDZ5LWVYZ0dRTE44MTFNaWlpdVY1WnluQXE1U0ZTYWsxd2h3Z2tKbVJtUlo5WE52eklGUUIzaEVibEthMVhENURsN0dUZjI0TGFwN2FDZG9JOTJSUWdzV0E1eFV6RXllMHJ0VnVzSndoMzZXZThXVQ?oc=5","date":"2022-06-06","type":"deal","source":"Fierce Biotech","summary":"Yumanity's end: J&J pays $26M for neuroscience assets as reverse merger erases biotech - Fierce Biotech","headline":"Yumanity's end: J&J pays $26M for neuroscience assets as reverse merger erases biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPLVFmaE4ya01QU0d3UnBYc3pJMUQ4eEV0ZzQwTGs1ZEkzT1o4YWRFWmlHbmtKRFJVejh4LUkySF82ZExmaHZwY08xSUI1S2dvN2dEY2t5Qnd3LUt2OUN2dEFfM2pKNHZDRGVXUDJrYTZ0QWdhZXFhOEZHOTR5UXVOTTdLOUdvbFlHMi1lRlkyNzNfMlB5bTl2ZnNfR2t4SkJzT1Zuc9IBqgFBVV95cUxNUXRIbFJfOGdRQnpWWlBUNFhRVWZ3NHkxdHdrZXRIRXdEcDlNV29FbmhSRndqNTZ4em5sN1pJZ2w2bzFoOUZmN3N3aTg1TW5ZUUo4bTJVelRDai1tQnhBWkRqeFZFa0VMYW0yTHB6UWZBMWVQVHg1enZvUG9LUkYwM2E4SUxOVF9ZcmU1MkhTTk5BcGprNDR1a1lWSTRxYXNleXU1WmNlRENuQQ?oc=5","date":"2018-04-16","type":"deal","source":"CNBC","summary":"Kineta inks $360 million-plus deal with Genentech for chronic pain drug - CNBC","headline":"Kineta inks $360 million-plus deal with Genentech for chronic pain drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOblAzczhpNmsxX0V0emx5UWR5SGxOVUlQOXVVdTh3Mk1peHVqWkZ2OC1XVld3aUYxODF2cW9ELVlzNXRXUVlYWHUwLVg4Ny1YMERXRXQzaVgtR09ZV3ZRY2lRdl83Y25PRm5KNGdyMWx4Qy1XQy05dk5BN0QyT19mbUJwbzE1a194SEN5ZXR5YWE5WDJvNkE?oc=5","date":"2018-04-16","type":"deal","source":"BioPharma Dive","summary":"Kineta, Roche’s Genentech strike chronic pain deal - BioPharma Dive","headline":"Kineta, Roche’s Genentech strike chronic pain deal","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}